TY  - THES
N2  - The human immune system’s relationship with cancer is incredibly complex. However, suggestions that the immune system can treat cancer have kept scientists searching for potential ways to augment immunity for over 100 years. We hypothesize that overcoming immune tolerance and activating a functional anti-tumor T cell response in cancer patients requires sufficient antigenic targets, tumor-specific primed T cells, the proper costimulatory signals, and the right cytokine milieu.
DO  - 10.6083/m42v2f7b
DO  - DOI
AB  - The human immune system’s relationship with cancer is incredibly complex. However, suggestions that the immune system can treat cancer have kept scientists searching for potential ways to augment immunity for over 100 years. We hypothesize that overcoming immune tolerance and activating a functional anti-tumor T cell response in cancer patients requires sufficient antigenic targets, tumor-specific primed T cells, the proper costimulatory signals, and the right cytokine milieu.
T1  - Augmenting combination immunotherapies with vaccination or costimulatory/inhibitory antibodies for the treatment of cancer
DA  - 2016
AU  - Messenheimer, David J.
L1  - https://digitalcollections.ohsu.edu/record/7685/files/Messenheimer.David.2016.pdf
PB  - Marylhurst University: Oregon Health and Science University
PY  - 2016
ID  - 7685
L4  - https://digitalcollections.ohsu.edu/record/7685/files/Messenheimer.David.2016.pdf
KW  - Immunotherapy 
KW  - Antibodies
KW  - Vaccines 
KW  - Neoplasms 
TI  - Augmenting combination immunotherapies with vaccination or costimulatory/inhibitory antibodies for the treatment of cancer
Y1  - 2016
L2  - https://digitalcollections.ohsu.edu/record/7685/files/Messenheimer.David.2016.pdf
LK  - https://digitalcollections.ohsu.edu/record/7685/files/Messenheimer.David.2016.pdf
UR  - https://digitalcollections.ohsu.edu/record/7685/files/Messenheimer.David.2016.pdf
ER  -